Archives

Tempest Therapeutics has appointed Ginna Laport chief medical officer of the San Francisco company. Laport comes to Tempest from Burlingame,

[Source: Research & Innovation] The main trend in the EU-28 research and innovation (R&I) performance is the emergence of a

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-MG-2018-2019-2020Pillar: Societal ChallengesOpening Date: Deadline: Wed, 31 Jan 2018 17:00:00 (Brussels local time)Modification Date: Wed, 5 Sep

David Schenkein, the longtime CEO of Agios Pharmaceuticals, will step aside next year after transforming what was once a high-risk

[Source: Research & Innovation] Jointly organised by ERTRAC, EGVIA and the European Commission’s Transport R&I Directorate, this 2nd European conference

Brazil’s vast, fertile landscape – covering 47 percent of the South American continent – is known for its biodiversity. And

One of their first investments is in biotech company Cambridge Epigenetix for $10 million. So far, the Ahren fund has

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-FETHPC-2018-2020Pillar: Excellent ScienceOpening Date: Deadline: Tue, 15 May 2018 17:00:00 (Brussels local time)Modification Date: Mon, 3 Sep

I am always in search of good scientific presentations in the biotech/life sciences area, and I love a good presentation.

Have you been asked to attach a cover letter to your job application? Perhaps you’re struggling to write one that lands